Spectrum begins Phase 2 Glioblastoma Multiforme study
The international, multicentre, randomised trial will evaluate the safety and efficacy of lucanthone administered in combination with temozolomide (TMZ) and radiation treatment. Spectrum Pharmaceuticals chairman, president and chief
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.